Papers/PMID:26283217
Enteral glutamine supplementation in critically ill patients: a systematic review and meta-analysis.
Critical care (London, England)2015The record
1 finding drawn from this paper, on 1 compound across 1 endpoint, 1 of them null.
What it reported
How to read these marksEvery finding here is a null result.
What did not
1 finding
L-glutamine — no detected effect on infectious complication rate
LikelyGrade B, Likely. Human evidence, limited replication or design limits.FindingNull resultreplicated ×1“When the four studies in which the researchers reported infectious complications were aggregated, enteral GLN supplementation was not associated with a reduction in infectious complications (RR 0.93, 95 % CI 0.79–1.10, p =0.39; heterogeneity I2 = 0 %) (Fig..”
Quoted verbatim from Enteral glutamine supplementation in critically ill patients: a systematic review and meta-analysis.. - Study
- meta-analysis
- Participants
- 776
- Population
- Adult critically ill ICU patients given enteral glutamine against an isonitrogenous control; secondary endpoint (primary was hospital mortality); 4 pooled trials; infection defined by each source trial
Effect 0.93 risk ratio, 95% CI 0.79 to 1.1
Enteral glutamine supplementation in critically ill patients: a systematic review and meta-analysis.2015PMID:26283217